Chen, Jacinda
Cazenave-Gassiot, Amaury http://orcid.org/0000-0002-3050-634X
Xu, Yimeng
Piroli, Paola
Hwang, Robert Jr.
DeFreitas, Laura
Chan, Robin Barry
Di Paolo, Gilbert http://orcid.org/0000-0003-1032-1265
Nandakumar, Renu
Wenk, Markus R.
Marquer, Catherine http://orcid.org/0000-0002-4064-9213
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health (AG078682, AG056758)
U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health
Article History
Received: 6 July 2022
Accepted: 9 February 2023
First Online: 23 February 2023
Competing interests
: R.B.C. is a current employee and shareholder of AliveX Biotech. G.D.P. is a current employee and shareholder of Denali Therapeutics Inc. The other authors declare no competing financial interests.